Financing Cash Flow
ResMed Financing Cash Flow increased by 1.2% to -$255.24M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 77.2%, from -$144.07M to -$255.24M. Over 2 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -11.0% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$114.04M | $92.97M | -$217.97M | -$60.86M | -$41.88M | $932.90M | -$279.56M | -$151.13M | -$238.96M | -$335.91M | -$393.28M | -$150.76M | -$147.54M | -$144.07M | -$163.89M | -$230.27M | -$258.35M | -$255.24M |
| QoQ Change | — | +181.5% | -334.5% | +72.1% | +31.2% | >999% | -130.0% | +45.9% | -58.1% | -40.6% | -17.1% | +61.7% | +2.1% | +2.3% | -13.8% | -40.5% | -12.2% | +1.2% |
| YoY Change | — | — | — | — | -145.0% | +528.0% | -359.4% | -260.9% | -125.6% | -20.2% | — | +0.2% | +38.3% | +57.1% | +58.3% | -52.7% | -75.1% | -77.2% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is ResMed's financing cash flow?
- ResMed (RMD) reported financing cash flow of -$255.24M in Q1 2026.
- How has ResMed's financing cash flow changed year-over-year?
- ResMed's financing cash flow decreased by 77.2% year-over-year, from -$144.07M to -$255.24M.
- What is the long-term trend for ResMed's financing cash flow?
- Over 2 years (2021 to 2025), ResMed's financing cash flow has grown at a -11.0% compound annual growth rate (CAGR), from -$764.63M to -$606.25M.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.